Navigation Links
BIDMC Dyslexia Research Lab celebrates 25th anniversary
Date:10/17/2007

BOSTON -- In the 25 years since establishing the Dyslexia Research Laboratory at Beth Israel Deaconess Medical Center (BIDMC), Albert Galaburda, MD, has witnessed a dramatic transformation in thinking among both scientists and the public.

Over the years, there have been a host of explanations offered to explain dyslexia, says Galaburda, Chief of the Division of Behavioral Neurology at BIDMC whose work has played a key role in influencing the field. Impaired vision, head injuries, inner-ear disorders and even laziness have all been attributed to the reading disorder, he notes.

It wasnt until the early 1980s that Galaburda and members of his laboratory discovered that the brains of individuals with dyslexia actually involve a pattern of structural and cellular abnormalities that account for the reading disorder.

Now, with the increasing availability of sophisticated imaging technologies and the sequencing of the human genome, we have made tremendous progress in understanding the neurological basis for this disability, he adds. The past five years have significantly increased our understanding of the brain and how we learn.

On October 24, Galaburda and a group of leaders in the field of dyslexia research, will discuss recent discoveries including newly identified genes associated with the developmental disorder as well as the latest thinking among educators regarding this reading disability.

The day-long web conference, sponsored by The Dyslexia Foundation will be broadcast live from BIDMCs Dyslexia Research Laboratory, beginning at 9:30 am, Wednesday, October 24. Other participants will include Drake Duane, MD, Anthony Monaco, PhD, Ken Pugh, PhD, Joan Mele-McCarthy, DA, Tami Katzir, PhD, and Maryanne Wolf, PhD.

This web-cast conference is geared toward informing parents, teachers and students on the latest in neuroscience research, and to explain and demonstrate the most recent evidence-based reading prac
'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Dyslexia due to cerebellum abnormality
2. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
3. Dyslexia Gene Identified and Called "KIAA0319"
4. New ways developed to understand dyslexia
5. Research finds new explanations for dyslexia
6. Chromosome 6 has the Dyslexia Gene
7. Gene For Dyslexia Identified
8. Research Fund for FSU to Eradicate Dyslexia
9. Chiropractic Care Helps Children With Learning Disorders and Dyslexia
10. Kidney Stones - Interesting New Research implicates bacteria as its cause
11. Stem cell research- now Nobel Laureates join the debate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... , , NEW YORK, Jan. 8 /PRNewswire-USNewswire/ -...ederations of North America today committed to rai...needs in southern Israel, part of a major initiati...s during the current conflict with Hamas, the terr..., , The funds will enhance programs supported b...
(Date:1/8/2009)...The physicians of Northern Lake Medical,Ltd., a p...n Illinois,communities, announced today that they...hoto: http://www.newscom.com/cgi-bin/prnh/2009010...ysicians serve patients through clinics in,the La...ox Lake. , "The Northern Lake Medical physi...
(Date:1/8/2009)...e National eHealth Collaborative, formerly AHIC Su...organizational leadership elections in which Kevin... was elected to serve as Vice Chair of the organiz...e builds on the accomplishments of the American He...ory committee established in 2005, and AHIC Succes...
(Date:1/8/2009)... -->, ,Researchers at McGill University, ...alth Centre (RI MUHC) and the McGill University an...gues at other Canadian and Belgian institutions, h...ases susceptibility to developing Crohn,s disease.... the journal Nature Genetics . , The study was ...
Breaking Medicine News(10 mins):Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3
...uggested that Women with disproportionate or uneve...cancer. Fortunately// , the mammography is designe...st, the study has revealed. A University of Live...mmograms of 252 women who developed cancer were co...
...also known as ice has resulted in increasing numbe...e increasing number of cases// and they are strugg...ow that about one in four ice addicts have a psych...ital has recorded a five-fold increase in patients...
...chers from the University of Michigan and Harvard ...ogy to explore how different regions// of the brai...ies of brands and products. The study, forthcoming...is the first to use fMRI to assess consumer percep...
...irector Homi Adajania's English film "Being Cyrus"...depicting older women in roles that explore their ...bai film features Dimple Kapadia as Katy, a Parsi ... essayed by Saif Ali Khan. The film also stars Nas...
Other Medicine News:Health News:Needed, more space for women's sexual identity on marquees 2Health News:Needed, more space for women's sexual identity on marquees 3Health News:Needed, more space for women's sexual identity on marquees 4
(Date:1/8/2009)...rk,s second indication with clinical-stage, system..., FREMONT, Calif., Jan. 8 Quark Ph...tical company discovering and developing novel RNA...ounced that it has initiated patient dosing in its...ally administered siRNA drug candidate QPI-1002 (p...
(Date:1/8/2009)...Validate Novel Gene Expression Biomarkers Involved...Platform , , FREMONT, Calif., Jan. 8 /PRNewswir...letin Board: WGBS), a leading developer of state-o...y and stem cell research systems, today announced ...University of Texas Southwestern Medical Center f...
(Date:1/8/2009)... -- If you are taking prescription medicine,and f...the people taking,prescription medicine don,t tak...y forget, are busy with other priorities, or make ...en called the Achilles heel of modern,healthcare.... "Drugs don,t,work in people who don,t take them....
(Date:1/8/2009)...hio, Jan. 8 IntelligentMDx a develo...ssays, today announced that verification studies o...re complete. , , Under the verification protoc...and reproducibility and robustness of the BK Viral...in agreed with internally generated analytical per...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 1Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 2Solar flares set the Sun quaking 2957 1Solar flares set the Sun quaking 2957 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 1HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 3Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 1Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 3
...and BASEL, Switzerland, June 27 /CNW/ -,Aspreva Ph... and,Roche today released preliminary results for ...olate mofetil, MMF) to intravenous,cyclophosphamid...r,inducing treatment response in the induction pha...though response rates were similar in both arms, t...
...IRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT)...reclinical,data that support the safety, activity,...brotide in combination with anticancer,therapy in ...update,from the Company,s ongoing Phase I/II clini... multiple myeloma with Defibrotide in,combination ...
Other Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads.
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy.
...g device for finger and alternate site testing fro... Comfort Zone Technology and Force Adjustment that... Comfort Zone Technology increases comfort when la... pain. This approach masks the pain of lancing to ...
Reduce the pain and hassle of testing. Unlike conventional lancing systems, the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing, with les
Medicine Products: